Navigation Links
Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
Date:4/23/2012

ST. LOUIS, April 23, 2012 /PRNewswire/ -- Young Innovations, Inc. (NASDAQ: YDNT) today announced sales and earnings per share for the quarter ended March 31, 2012. 

Sales for the first quarter of 2012 were $26.8 million, an increase of 2.8% from $26.0 million reported in the first quarter of 2011. Income from operations increased 5.3% to $6.1 million in the first quarter of 2012 from $5.8 million in the first quarter of 2011. Net income increased 5.6% to $4.2 million compared with $4.0 million in the first quarter of 2011. Diluted earnings per share increased 8.0% in the first quarter of 2012 to $0.54 from $0.50 in the prior year quarter.

We are pleased with the Company's sales performance in the quarter. Sales continued to benefit from solid overall demand and recent new product introductions under both our consumable and diagnostic product lines. Favorable product mix and increases in operating efficiencies helped improve our operating income for the quarter. The Company also recognized a gain in the quarter from its private equity investment of approximately $0.04 per share, which was recorded as "other income." In the first quarter of 2011, the Company also recorded a gain of $0.04 per share from the private equity investment.

We remain focused on driving internal growth through enhancing customer relationships, increasing operating efficiencies, and new product development. During the quarter, we continued to focus on the launch of new cup styles under our popular Elite polishing line. We enhanced our e-commerce capabilities to improve our online interactions with customers. We also invested in new capital equipment to increase production capacity. Finally, we ended the quarter with $5.2 million of cash on our balance sheet, up $4.2 million from the end of 2011.

A conference call has been scheduled for Tuesday, April 24, 2012 at 10:00 A.M. Central Time and can be accessed through InterCall at http://tinyurl.com/YI-Quarter12012 or on the Company's website, www.ydnt.com.

Young Innovations develops, manufactures and markets supplies and equipment used by dentists, dental hygienists, dental assistants and consumers. The Company's consumables product offering includes disposable and metal prophy angles, prophy cups and brushes, dental micro-applicators, moisture control products, infection control products, dental handpieces (drills) and related components, endodontic systems, orthodontic toothbrushes, flavored examination gloves, children's toothbrushes, and children's toothpastes. In addition, the Company offers a line of diagnostic products that includes panoramic X-ray machines and related supplies. The Company believes it is a leading U.S. manufacturer or distributor of prophy angles and cups, liquid surface disinfectants, dental micro-applicators and obturation units designed for warm, vertical condensation.

Investors are cautioned that this press release as well as other reports and oral statements by Company officials may contain certain forward-looking statements as defined in the Private Securities Litigation and Reform Act of 1995.  Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions and which include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," or similar expressions.  These statements are not guaranties of future performance and the Company makes no commitment to update or disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that may bear upon forward-looking statements.  Because such statements involve risks and uncertainties, actual actions and strategies and the timing and expected results thereof may differ materially from those expressed or implied by such forward-looking statements.  These risks and uncertainties include, but are not limited to, those disclosed in the Company's Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission.Young Innovations, Inc.Consolidated Statements of Income(In thousands, except earnings per share data)(Unaudited)(In Thousands USD)Three Months EndedMarch 31,20122011

ChangeNet Sales

$
26,754$
26,024

2.8%Cost of Goods Sold

$
,762$
,561

1.7%Gross Profit

$
4,992$
4,463

3.7%% of Net Sales

56.0%55.6%Selling, General and Administrative Expense

$
8,918$
8,697

2.5%% of Net Sales

33.3%33.4%Income from Operations

6,0745,766

5.3%% of Net Sales

22.7%22.2%Interest expense, net

5573Other (income) expense, net

(494)(433)Income Before Taxes

6,5136,126

6.3%Provision for Income Taxes

2,2902,126Net Income

$
4,223$
4,000

5.6%% of Net Sales

15.8%15.4%Basic Earnings Per Share 

$
.54$
.50

8.0%Basic Weighted Average Shares Outstanding

7,8868,010Earnings Per Share (Diluted)

$
.54$
.50

8.0%Diluted Weighted Average Shares Outstanding

7,8938,074 

 YI ConsolidatedConsolidated Balance SheetMarch 31, 2012 and December 31, 2011(In Thousands USD)(Unaudited)March 31December 31Assets20122011Current assetsCash$
5,201$
,031Accounts receivable, net11,98012,066Inventories16,93217,161Other current assets4,9444,729Total current assets39,05734,987Property, plant and equipment, net31,80132,272Goodwill80,28880,254Intangible assets11,00211,130Other assets8251,143Total assets$
2,973$
59,786Liabilities and EquityCurrent liabilitiesAccounts payable and accrued liabilities$
,042$
9,134Total current liabilities10,0429,134Long-term debt-650Long-term secured borrowing99Deferred income taxes19,53419,534Other noncurrent liabilities204206Total liabilities29,78929,533Stockholders' equityCommon stock102102Additional paid-in capital24,02724,708Retained earnings162,556158,647Common stock in treasury, at cost(53,310)(52,924)Accumulated other comprehensive income(191)(280)Total stockholders' equity133,184130,253Total liabilities and stockholders' equity$
2,973$
59,786 


'/>"/>
SOURCE Young Innovations, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Younger Adults Increasingly Treated for Heart Disease-related Conditions
2. New Risk Factor for Heart Disease Identified in Very Young Children, According to Study at American Heart Association Scientific Sessions
3. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
4. Mayo Clinic Study Identifies Potential Causes of Young-Onset Dementia
5. St. Jude Finds Young Age May Give Survival Advantage to Children With Certain Brain Tumors
6. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
7. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
8. Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women
9. Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
10. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
11. Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences Inc. ... to support the development of CRISPR-Cas3 antimicrobial therapeutics. Financing ... a leading Chinese Internet services provider, and joined by ... multiple infectious disease product programs targeting antibiotic resistant infections ... Founded by Dr. Rodolphe Barrangou and ...
(Date:7/5/2017)... a company of over 2,000 employees and a leader in environmental and life ... solidifying their position as the top American owned and operated environmental testing firm ... ... ... TN , enhances Pace Analytical,s capability as an innovative full service provider ...
(Date:6/30/2017)... , June 30, 2017  AVACEN Medical (AVACEN) announced the ... The research describes the use of its AVACEN Treatment Method ... suffering from fibromyalgia. ... AVACEN Medical ... characterized by chronic widespread pain. It affects approximately 200 to 400 million ...
Breaking Medicine Technology:
(Date:7/21/2017)... ORLEANS, La. (PRWEB) , ... July 21, 2017 ... ... to allow 4th-year medical students improve their chances of acceptance to a residency ... for those who have earned degrees outside the U.S. , According to data ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital ... adjustable beds used in such facilities are specially designed to accommodate patients with a ... , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, ...
(Date:7/20/2017)... MD (PRWEB) , ... July 20, 2017 , ... ... company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary ... million. , Proceeds will be used to complete regulatory submissions and fund final ...
Breaking Medicine News(10 mins):